AnalystsJohn WilkinJohn Wilkin's Stock Forecasts
AnalystsJohn Wilkin
Sectors:
Industries:
Analyst Ranking
Top 33%
#1847 out of 5550 analysts
Average Return
+37.5%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
John Wilkin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exagen IncXGN | +176.21% | $3.11 | $8.59 | 2026-03-11 - 2026-10-30 | Buy |
Personalis IncPSNL | +78.68% | $3.80 | $6.79 | 2025-03-17 - 2026-03-16 | Buy |
Adaptive Biotechnologies CorpADPT | +60.27% | $10.47 | $16.78 | 2025-06-18 - 2026-06-17 | Buy |
Myriad Genetics IncMYGN | +39.87% | $4.54 | $6.35 | 2026-10-02 - 2026-10-30 | Buy |
Veracyte IncVCYT | +2.95% | $31.84 | $32.78 | 2025-03-20 - 2026-03-19 | Buy |
John Wilkin Analyst Color
Get additional color on John Wilkin's coverage of popular stocks
John Wilkin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Myriad Genetics IncMYGN | 2 | Buy | $8.00 | +25.98% | Maintains | a month ago |
Exagen IncXGN | 2 | Buy | $10.00 | +16.41% | Maintains | 8 months ago |
Adaptive Biotechnologies CorpADPT | 1 | Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Veracyte IncVCYT | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Personalis IncPSNL | 1 | Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.